Nisa Investment Advisors, LLC Ligand Pharmaceuticals Inc Transaction History

Nisa Investment Advisors, LLC

  • $24.1 Billion
  • Q4 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 793 shares of LGND stock, worth $91,876. This represents 0.0% of its overall portfolio holdings.

Number of Shares
793
Previous 758 4.62%
Holding current value
$91,876
Previous $75,000 12.0%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025
BUY
$99.95 - $129.9 $3,498 - $4,546
35 Added 4.62%
793 $84,000
Q3 2024

Oct 24, 2024
BUY
$82.7 - $110.11 $165 - $220
2 Added 0.26%
758 $75,000
Q2 2024

Jul 19, 2024
BUY
$68.53 - $87.91 $1,027 - $1,318
15 Added 2.02%
756 $63,000
Q1 2024

May 01, 2024
BUY
$68.64 - $89.2 $1,029 - $1,338
15 Added 2.07%
741 $54,000
Q4 2023

Jan 25, 2024
BUY
$49.57 - $72.63 $495 - $726
10 Added 1.4%
726 $51,000
Q3 2023

Nov 02, 2023
SELL
$58.86 - $72.67 $470 - $581
-8 Reduced 1.1%
716 $42,000
Q2 2023

Aug 11, 2023
BUY
$69.53 - $79.33 $4,171 - $4,759
60 Added 9.04%
724 $52,000
Q3 2022

Nov 07, 2022
BUY
$0.01 - $107.56 $0 - $1,290
12 Added 1.84%
664 $58,000
Q2 2022

Aug 03, 2022
SELL
$74.52 - $117.06 $7,452 - $11,706
-100 Reduced 13.3%
652 $58,000
Q1 2022

Apr 29, 2022
BUY
$94.99 - $151.56 $3,514 - $5,607
37 Added 5.17%
752 $85,000
Q1 2021

Apr 26, 2021
BUY
$99.52 - $215.83 $19,904 - $43,166
200 Added 38.83%
715 $109,000
Q4 2020

Jan 25, 2021
SELL
$80.55 - $106.05 $48,330 - $63,630
-600 Reduced 53.81%
515 $51,000
Q3 2020

Oct 20, 2020
BUY
$89.56 - $126.72 $48,362 - $68,428
540 Added 93.91%
1,115 $106,000
Q2 2020

Jul 27, 2020
SELL
$68.28 - $123.65 $65,207 - $118,085
-955 Reduced 62.42%
575 $64,000
Q1 2020

Apr 17, 2020
BUY
$63.37 - $107.88 $17,109 - $29,127
270 Added 21.43%
1,530 $111,000
Q4 2019

Jan 17, 2020
BUY
$96.94 - $113.59 $19,388 - $22,718
200 Added 18.87%
1,260 $131,000
Q3 2019

Oct 17, 2019
BUY
$86.25 - $120.16 $82,800 - $115,353
960 Added 960.0%
1,060 $106,000
Q4 2018

Jan 17, 2019
SELL
$128.36 - $272.13 $993,891 - $2.11 Million
-7,743 Reduced 98.72%
100 $14,000
Q3 2018

Oct 16, 2018
BUY
$211.18 - $274.49 $1.62 Million - $2.11 Million
7,693 Added 5128.67%
7,843 $2.15 Million
Q2 2018

Jul 19, 2018
BUY
$150.77 - $207.98 $7,538 - $10,399
50 Added 50.0%
150 $31,000
Q1 2018

Apr 10, 2018
SELL
$138.63 - $182.62 $6,931 - $9,131
-50 Reduced 33.33%
100 $17,000
Q3 2017

Oct 13, 2017
BUY
$120.91 - $137.94 $18,136 - $20,691
150
150 $20,000

Others Institutions Holding LGND

# of Institutions
257
Shares Held
18.1M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.96B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email